These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23616580)

  • 1. The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions.
    Niyonsaba F; Madera L; Afacan N; Okumura K; Ogawa H; Hancock RE
    J Leukoc Biol; 2013 Jul; 94(1):159-70. PubMed ID: 23616580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
    Nijnik A; Madera L; Ma S; Waldbrook M; Elliott MR; Easton DM; Mayer ML; Mullaly SC; Kindrachuk J; Jenssen H; Hancock RE
    J Immunol; 2010 Mar; 184(5):2539-50. PubMed ID: 20107187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
    Lee HY; Bae YS
    Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.
    Yanashima K; Chieosilapatham P; Yoshimoto E; Okumura K; Ogawa H; Niyonsaba F
    Immunol Res; 2017 Aug; 65(4):920-931. PubMed ID: 28653285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils.
    Zheng Y; Niyonsaba F; Ushio H; Nagaoka I; Ikeda S; Okumura K; Ogawa H
    Br J Dermatol; 2007 Dec; 157(6):1124-31. PubMed ID: 17916212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation.
    Zheng Y; Niyonsaba F; Ushio H; Ikeda S; Nagaoka I; Okumura K; Ogawa H
    Immunology; 2008 Jul; 124(3):357-67. PubMed ID: 18194266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
    Choe H; Narayanan AS; Gandhi DA; Weinberg A; Marcus RE; Lee Z; Bonomo RA; Greenfield EM
    Clin Orthop Relat Res; 2015 Sep; 473(9):2898-907. PubMed ID: 25953690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines.
    Madera L; Hancock RE
    Biochem Biophys Res Commun; 2015 Aug; 464(3):800-6. PubMed ID: 26168734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin.
    Madera L; Hancock RE
    J Innate Immun; 2012; 4(5-6):553-68. PubMed ID: 22722749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts.
    Turner-Brannen E; Choi KY; Lippert DN; Cortens JP; Hancock RE; El-Gabalawy H; Mookherjee N
    Arthritis Res Ther; 2011 Aug; 13(4):R129. PubMed ID: 21835002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.
    Mansour SC; de la Fuente-Núñez C; Hancock RE
    J Pept Sci; 2015 May; 21(5):323-9. PubMed ID: 25358509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate defense regulator peptide 1018 in wound healing and wound infection.
    Steinstraesser L; Hirsch T; Schulte M; Kueckelhaus M; Jacobsen F; Mersch EA; Stricker I; Afacan N; Jenssen H; Hancock RE; Kindrachuk J
    PLoS One; 2012; 7(8):e39373. PubMed ID: 22879874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide.
    Bommineni YR; Pham GH; Sunkara LT; Achanta M; Zhang G
    Mol Immunol; 2014 May; 59(1):55-63. PubMed ID: 24491488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory activities of small host defense peptides.
    Bowdish DM; Davidson DJ; Scott MG; Hancock RE
    Antimicrob Agents Chemother; 2005 May; 49(5):1727-32. PubMed ID: 15855488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular receptor for human host defense peptide LL-37 in monocytes.
    Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
    J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.
    Wuerth KC; Falsafi R; Hancock REW
    PLoS One; 2017; 12(11):e0187565. PubMed ID: 29107983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host defense peptides and their antimicrobial-immunomodulatory duality.
    Steinstraesser L; Kraneburg U; Jacobsen F; Al-Benna S
    Immunobiology; 2011 Mar; 216(3):322-33. PubMed ID: 20828865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.
    Rivas-Santiago B; Castañeda-Delgado JE; Rivas Santiago CE; Waldbrook M; González-Curiel I; León-Contreras JC; Enciso-Moreno JA; del Villar V; Mendez-Ramos J; Hancock RE; Hernandez-Pando R
    PLoS One; 2013; 8(3):e59119. PubMed ID: 23555622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators.
    Borgquist JD; Quinn MT; Swain SD
    J Leukoc Biol; 2002 May; 71(5):764-74. PubMed ID: 11994500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.
    Kanazawa K; Okumura K; Ogawa H; Niyonsaba F
    Immunol Res; 2016 Apr; 64(2):594-603. PubMed ID: 26663017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.